Eosinopenia as a Prognostic Biomarker for Noninvasive Ventilation Use in COPD Exacerbations

被引:3
|
作者
Bartziokas, Konstantinos [1 ,2 ]
Papathanasiou, Evgenia [2 ]
Papaioannou, Andriana I. I. [2 ]
Papanikolaou, Ilias [3 ]
Antonakis, Emmanouil [3 ]
Makou, Ioanna [3 ]
Hillas, Georgios [4 ]
Karampitsakos, Theodoros [4 ]
Papaioannou, Ourania [4 ]
Dimakou, Katerina [4 ]
Apollonatou, Vasiliki [2 ]
Verykokou, Galateia [2 ]
Papiris, Spyros [2 ]
Bakakos, Petros [5 ]
Loukides, Stelios [2 ]
Kostikas, Konstantinos [1 ]
机构
[1] Univ Ioannina, Resp Med Dept, Ioannina 45110, Greece
[2] Natl & Kapodistrian Univ Athens, Resp Med Dept 2, Athens 10679, Greece
[3] Corfu Gen Hosp, Resp Med Dept, Corfu 49100, Greece
[4] Sotiria Chest Hosp, Resp Med Dept 5, Athens 11527, Greece
[5] Natl & Kapodistrian Univ Athens, Resp Med Dept 1, Athens 10676, Greece
来源
JOURNAL OF PERSONALIZED MEDICINE | 2023年 / 13卷 / 04期
关键词
COPD; exacerbations; eosinophils; hospital admission; non-invasive ventilation; OBSTRUCTIVE PULMONARY-DISEASE; HOSPITALIZED EXACERBATIONS; MECHANICAL VENTILATION; BLOOD EOSINOPHILS; INFECTION; OUTCOMES;
D O I
10.3390/jpm13040686
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: In recent years, blood eosinophils have been evaluated as a surrogate biomarker for eosinophilic airway inflammation and as a prognostic indicator of the outcomes of hospitalized COPD subjects. During an exacerbation of COPD, eosinopenia has been proposed as a prognostic marker of adverse outcomes. Objectives: The aim of the present post hoc analysis was to elucidate the effectiveness of blood eosinophils for predicting the need of NIV in subjects with COPD exacerbation. Methods: Consecutive subjects admitted to a hospital for COPD exacerbation were included in the analysis. The eosinophil count from the first complete blood count was used to designate the eosinophil groups. The relationship between the clinical characteristics and blood eosinophil counts, as dichotomized using 150 cells/mu L, was evaluated. Results Subjects with blood eosinophil number < 150 k/mu L had a more severe disease on admission compared to subjects with >= 150 k/mu L, regarding pH 7.400 (7.36, 7.44) vs. 7.42 (7.38, 7.45), p = 0.008, PO2/FiO(2) levels 238.1 (189.8, 278.6) vs. 276.2 (238.2, 305.6), p < 0.001, CRP (mg/L) levels 7.3 (3.1, 19.9) vs. 3.5 (0.7, 7.8), p < 0.001 and required a longer hospital stay (days) 10.0 (8.0, 14.0) vs. 5.0 (3.0, 7.0) p < 0.001 respectively. The number of blood eosinophils correlated with the levels of CRP upon admission (p < 0.001, r = -0.334), with arterial pH upon admission (p < 0.030, r = 0.121), with PO2/FiO(2) (p < 0.001, r = -0.248), and with duration of hospital stay (p < 0.001, r = -0.589). In the multinomial logistic regression analysis, blood eosinophil count < 150 k/mu L was an independent predictor of the use of NIV during hospital stay. Conclusion: During COPD exacerbation, low blood eosinophil levels upon admission are related to more severe disease and can be used as a predictor of the need of NIV. Further prospective studies are needed to identify the use of blood eosinophil levels as a predictor of unfavorable outcomes.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Noninvasive ventilation in acute exacerbations of COPD
    Elliott, M. W.
    EUROPEAN RESPIRATORY REVIEW, 2005, 14 (94): : 39 - 42
  • [2] Sequential use of noninvasive pressure support ventilation for acute exacerbations of COPD
    G. Hilbert
    D. Gruson
    G. Gbikpi-Benissan
    J. P. Cardinaud
    Intensive Care Medicine, 1997, 23 : 955 - 961
  • [3] Sequential use of noninvasive pressure support ventilation for acute exacerbations of COPD
    Hilbert, G
    Gruson, D
    GbikpiBenissan, G
    Cardinaud, JP
    INTENSIVE CARE MEDICINE, 1997, 23 (09) : 955 - 961
  • [4] Eosinopenia as a biomarker for antibiotic use in COPD exacerbations: protocol for a retrospective hospital-based cohort study
    Yang, Mei
    Liu, Xuemei
    Hu, Qiongqiong
    Li, Junjie
    Fu, Sijia
    Chen, Daohong
    Wu, Yanqing
    Luo, Ai
    Zhang, Xiawei
    Feng, Ruizhi
    Xu, Guo
    Liu, Can
    Jiang, Hongli
    Liu, Wei
    BMJ OPEN, 2022, 12 (01):
  • [5] PREDICTORS OF NONINVASIVE VENTILATION FAILURE IN PATIENTS WITH COPD EXACERBATIONS IN THE ICU
    Ghazala, Laith
    Hatipoglu, Umur
    Duggal, Abhijit
    Devnani, Tanya
    Covert, Erin
    Hanks, Justin
    Fiore, Andrew
    Edwards, Katelyn
    CHEST, 2019, 156 (04) : 243A - 244A
  • [6] The factors affecting noninvasive mechanical ventilation failure in COPD exacerbations
    Bacakoglu, Feza
    Tasbakan, Mehmet Sezai
    Basoglu, Ozen Kacmaz
    Oz, Adnan Tolga
    Urkmez, Sedat
    Midilli, Meltem
    Ekren, Pervin Korkmaz
    Gurgun, Alev
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2012, 42 (01) : 103 - 112
  • [7] Low Eosinophil Phenotype Predicts Noninvasive Mechanical Ventilation Use in Patients with Hospitalized Exacerbations of COPD
    Wei, Tingting
    Wang, Xiaocen
    Lang, Ke
    Chen, Cuicui
    Song, Yansha
    Luo, Jinlong
    Gu, Zhaolin
    Hu, Xianglin
    Yang, Dong
    JOURNAL OF INFLAMMATION RESEARCH, 2022, 15 : 1259 - 1271
  • [8] EFFECTS OF INTRAPULMONARY PERCUSSIVE VENTILATION AS COMPLEMENTARY TECHNIQUE IN NONINVASIVE MECHANICAL VENTILATION DURING EXACERBATIONS OF COPD
    Esquinas, A.
    Folgado, M.
    Serrano, J.
    INTENSIVE CARE MEDICINE, 2010, 36 : S388 - S388
  • [9] Home noninvasive ventilation use in patients hospitalized with COPD
    Fortis, Spyridon
    Gao, Yubo
    Rewerts, Kelby
    Sarrazin, Mary Vaughan
    Kaboli, Peter J.
    CLINICAL RESPIRATORY JOURNAL, 2023, 17 (08): : 811 - 815
  • [10] An audit of the use of non invasive ventilation in acute exacerbations of COPD
    Jolley, CJ
    Savine, R
    Ellum, S
    Gilleard, O
    Lams, BEA
    Davidson, AC
    THORAX, 2002, 57